SCHEMBL4903596

SCHEMBL4903596

CCc1ccc(S(=O)(=O)NCCc2coc(-c3ccc(C(F)(F)F)cc3)n2)cc1C(=O)OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.50
PPARA Q07869 3/20 0.50
LMNA P02545 4/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
KDM4E B2RXH2 2/20 0.44
POLB P06746 1/20 0.44
HTT P42858 1/20 0.44
GAA P10253 1/20 0.38
TP53 P04637 4/20 0.36
MAPT P10636 3/20 0.36
MMP1 P03956 1/20 0.36
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
ADRB2 P07550 1/20 0.35
ADRB1 P08588 1/20 0.35
ADRB3 P13945 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
KDM1A O60341 1/20 0.35
ALOX15 P16050 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906000 0.92 PPARG (0.41) PPARGPPARALMNASMN1; SMN2KDM4E
SCHEMBL4900873 0.92 PPARG (0.52) PPARGPPARALMNASMN1; SMN2KDM4E
SCHEMBL4906842 0.91 LMNA (0.45) PPARGPPARALMNASMN1; SMN2KDM4E
SCHEMBL4903863 0.86 PPARG (0.42) PPARGPPARALMNASMN1; SMN2KDM4E
SCHEMBL4899812 0.84 PPARG (0.43) PPARGPPARALMNASMN1; SMN2KDM4E
SCHEMBL4906505 0.84 LMNA (0.46) PPARGPPARALMNASMN1; SMN2KDM4E
SCHEMBL4900708 0.83 PPARG (0.41) PPARGPPARALMNASMN1; SMN2KDM4E
SCHEMBL4902454 0.81 LMNA (0.38) PPARGPPARALMNASMN1; SMN2KDM4E
SCHEMBL4911898 0.80 PPARG (0.44) PPARGPPARALMNASMN1; SMN2KDM4E
SCHEMBL4900694 0.79 MAPT (0.44) PPARGPPARALMNASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD PPARG 2/4885PPARA 1/4885LMNA 317/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD PPARG 2/4885PPARA 1/4885LMNA 319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.